All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study - PubMed (original) (raw)

All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study

Eveline Nüesch et al. BMJ. 2011.

Abstract

Objective: To examine all cause and disease specific mortality in patients with osteoarthritis of the knee or hip.

Design: Population based cohort study.

Setting: General practices in the southwest of England.

Participants: 1163 patients aged 35 years or over with symptoms and radiological confirmation of osteoarthritis of the knee or hip.

Main outcome measures: Age and sex standardised mortality ratios and multivariable hazard ratios of death after a median of 14 years' follow-up.

Results: Patients with osteoarthritis had excess all cause mortality compared with the general population (standardised mortality ratio 1.55, 95% confidence interval 1.41 to 1.70). Excess mortality was observed for all disease specific causes of death but was particularly pronounced for cardiovascular (standardised mortality ratio 1.71, 1.49 to 1.98) and dementia associated mortality (1.99, 1.22 to 3.25). Mortality increased with increasing age (P for trend <0.001), male sex (adjusted hazard ratio 1.59, 1.30 to 1.96), self reported history of diabetes (1.95, 1.31 to 2.90), cancer (2.28, 1.50 to 3.47), cardiovascular disease (1.38, 1.12 to 1.71), and walking disability (1.48, 1.17 to 1.86). However, little evidence existed for increased mortality associated with previous joint replacement, obesity, depression, chronic inflammatory disease, eye disease, or presence of pain at baseline. The more severe the walking disability, the higher was the risk of death (P for trend <0.001).

Conclusion: Patients with osteoarthritis are at higher risk of death compared with the general population. History of diabetes, cancer, or cardiovascular disease and the presence of walking disability are major risk factors. Management of patients with osteoarthritis and walking disability should focus on effective treatment of cardiovascular risk factors and comorbidities, as well as on increasing physical activity.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi\_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Figures

None

Fig 1 Flow of participants through different stages of study

None

Fig 2 Associations between characteristics at baseline and all cause mortality up to 15 years thereafter. Shows hazard ratios with corresponding 95% confidence intervals from multivariable Cox proportional hazards models after multiple imputation of missing values in covariates. P values were calculated by using two sided Wald tests. NSAIDs=non-steroidal anti-inflammatory drugs. *Age 35-54 as reference category. †Isolated knee osteoarthritis as reference category

None

Fig 3 All cause and disease specific mortality in patients with and without walking disability at baseline examination. Kaplan-Meier curves show the cumulative incidence of all cause mortality, death from cardiovascular causes, cancer related death, death from respiratory causes, death from gastrointestinal causes, and death associated with dementia up to 15 years

Comment in

Similar articles

Cited by

References

    1. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum 1998;41:1343-55. - PubMed
    1. Hochberg MC. Mortality in osteoarthritis. Clin Exp Rheumatol 2008;26:S120-4. - PubMed
    1. Myasoedova E, Davis JM, Crowson CS, Gabriel SE. Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. Curr Rheumatol Rep 2010;12:379-85. - PubMed
    1. Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009;11:229. - PMC - PubMed
    1. Snow MH, Mikuls TR. Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention. Curr Opin Rheumatol 2005;17:234-41. - PubMed

Publication types

MeSH terms

LinkOut - more resources